Alpha Particle Radiobiology for Radium-223 (“Alpharadin”): The Fortuitous “Goldilocks” Effect Observed for Hormone-resistant Metastatic Prostate Cancer

[1]  M. Niemantsverdriet,et al.  High and low LET radiation differentially induce normal tissue damage signals. , 2012, International journal of radiation oncology, biology, physics.

[2]  J. Staffurth,et al.  A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer. , 2012, European journal of cancer.

[3]  C. Hindorf,et al.  Clinical dosimetry in the treatment of bone tumors: old and new agents. , 2011, The Quarterly Journal of Nuclear Medicine and Molecular Imaging.

[4]  B. Wessels,et al.  MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy* , 2010, Journal of Nuclear Medicine.

[5]  K. Liepe.  Alpharadin, a 223Ra-based alpha-particle-emitting pharmaceutical for the treatment of bone metastases in patients with cancer. , 2009, Current opinion in investigational drugs.

[6]  S. Nilsson,et al.  High-Linear Energy Transfer Irradiation Targeted to Skeletal Metastases by the α-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities? , 2006, Clinical Cancer Research.

[7]  R. Larsen,et al.  Radiotoxicity of the alpha-emitting bone-seeker 223Ra injected intravenously into mice: histology, clinical chemistry and hematology. , 2006, In vivo.

[8]  J. Roeske,et al.  Targeting of osseous sites with alpha-emitting 223Ra: comparison with the beta-emitter 89Sr in mice. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  J. Humm,et al.  Morphological, biochemical, and molecular changes in endothelial cells after alpha-particle irradiation. , 1993, Radiation research.

[10]  G. Schoeters.  Dose delivered to various bone and marrow sites of radium 226 injected mice related to the observed heterogeneity in damage to haemopoietic marrow cells. , 1982, The British journal of radiology.

[11]  P. Groer,et al.  Dose to endosteal cells and relative distribution factors for radium-224 and plutonium-239 compared to radium-226. , 1978, Health physics.